Global Egg Protein In Pharmaceuticals Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 3.66 Billion |
 Market Size (Forecast Year) |
USD 6.06 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球药品用蛋白质市场细分，按类型（蛋清粉、蛋黄粉和全蛋蛋白）、口味（调味和普通）、形式（液体、粉末和固体）、功能（粘合、结晶、乳化、膨松、防腐剂和增稠）、应用（烘焙和糖果、膳食补充剂、饲料、食品和饮料、冰淇淋、肉制品、个人护理和化妆品、蛋白质和营养棒）、分销渠道（便利店、医疗和药店、网上商店和超市/大卖场）– 行业趋势和预测到 2031 年。
鸡蛋蛋白在医药市场中的分析和规模
鸡蛋蛋白在医药领域的市场由于其独特的功能特性和高营养价值而正在经历显著增长。该市场受益于药物制剂和生物制剂对高质量蛋白质来源日益增长的需求。鸡蛋蛋白作为有效稳定剂、乳化剂和载体的能力提高了药物化合物的溶解度和生物利用度，推动了其应用。此外，鸡蛋蛋白在疫苗生产中的使用，特别是流感和其他病毒疫苗，进一步支持了市场扩张。医疗支出的增加、制药技术的进步以及对有效药物输送系统的日益关注等因素促成了市场呈积极趋势。
鸡蛋蛋白在医药市场中的规模
2023 年全球药物用鸡蛋蛋白市场规模价值 36.6 亿美元，预计到 2031 年将达到 60.6 亿美元，2024 年至 2031 年预测期内的复合年增长率为 6.50%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深入的专家分析、按地理代表的公司生产和产能、分销商和合作伙伴的网络布局、详细和更新的价格趋势分析以及供应链和需求的缺口分析。
报告范围和市场细分
|
属性 |
鸡蛋蛋白在药品中的关键市场洞察 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022（可定制为 2016 - 2021） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
Type (Egg White Powder, Egg Yolk Powder, and Whole Egg Protein), Flavour (Flavoured and Regular), Form (Liquid, Powder, and Solid), Function (Binding, Crystallization, Emulsifying, Leavening, Preservatives, and Thickening), Application (Bakery and Confectionery, Dietary Supplements, Feed, Food and Beverages, Ice Cream, Meat Products, Personal Care and Cosmetics, and Protein and Nutritional Bars), Distribution Channel (Convenience Stores, Medical and Drug Stores, Online Store, and Supermarkets/Hypermarkets) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of the Middle East and Africa, Brazil, Argentina, Rest of South America. |
|
Market Players Covered |
Eat Just, Inc. (U.S.), IntegriCulture Inc. (Japan), Aleph Farms (Israel), AVANTMEATS (China), Believer Meats (U.S.), newprotein (Argentina), BioFood Systems Ltd. (Israel), Meatable (Netherlands), Mission Barns (U.S.), BlueNalu (U.S.), Simple Foods Inc. (U.S.), Shiok Meats (Singapore), CUBIQ FOODS S.L. (Spain) |
|
Market Opportunities |
|
Egg Protein in Pharmaceuticals Market Definition
Egg protein in pharmaceuticals refers to the use of proteins derived from eggs, particularly egg whites, in the development and formulation of pharmaceutical products. Egg proteins, known for their high biological value and rich amino acid profile, are utilized for their functional and nutritional properties. In pharmaceuticals, egg proteins are often used as stabilizers, emulsifiers, and carriers in drug formulations. Their ability to enhance the solubility and bioavailability of certain drugs makes them valuable in improving the efficacy of pharmaceutical products.
Egg Protein in Pharmaceuticals Market Dynamics
Drivers
- Effective Stabilization and Emulsification of Egg Proteins
Egg proteins are renowned for their superior stabilizing and emulsifying properties, which make them highly valuable in pharmaceutical applications. In drug formulations, egg proteins function as excellent stabilizers, maintaining the consistency and quality of the product by preventing the separation of ingredients. They also serve as effective emulsifiers, ensuring the uniform dispersion of immiscible substances such as oils and water. This capability is particularly crucial in complex formulations where precise consistency is essential for efficacy. By enhancing the stability and homogeneity of pharmaceutical products, egg proteins contribute to improved drug delivery systems and overall product performance, driving market growth.
- Growing Demand for Vaccines
Egg proteins play a pivotal role in the manufacturing of various vaccines, including those for influenza and other viral infections, where they serve as a medium for the growth of vaccine antigens. The ability of egg proteins to support the cultivation of these antigens ensures the effectiveness and safety of the vaccines. As the global need for biologics continues to rise due to the prevalence of infectious diseases and the expansion of vaccination programs, egg proteins remain integral to the production process. This growing demand for biologics and vaccines thus drives the market for egg proteins.
Opportunities
- Advancements in Pharmaceutical Technologies
New technologies, such as targeted drug delivery systems and novel formulations, often require specialized stabilizers and emulsifiers to enhance their performance and effectiveness. Egg proteins, with their unique functional properties, are well-suited for these advanced applications. As pharmaceutical companies seek to develop more efficient and effective drug delivery solutions, the demand for egg proteins is expected to rise. Innovations in pharmaceutical technologies, including advanced drug delivery systems and formulations, have created significant opportunities for the use of egg proteins.
- Rising Healthcare Expenditure
With healthcare budgets expanding and spending on pharmaceuticals rising, there is a greater emphasis on developing high-quality and effective drug formulations. Egg proteins, known for their superior stabilizing and emulsifying properties, are increasingly being utilized to meet these demands. This rise in healthcare expenditure supports the investment in advanced pharmaceutical products and technologies, further driving the market for egg proteins. As healthcare priorities continue to evolve and expand, the role of egg proteins in ensuring the quality and efficacy of pharmaceutical products becomes increasingly prominent. The increasing global expenditure on healthcare and pharmaceuticals is creating growth opportunities for the egg protein market.
Top of Form
Restraints/Challenges
- Availability of Alternative Proteins
The availability of alternative proteins and stabilizers poses a challenge to the reliance on egg proteins in pharmaceuticals. With the growing interest in plant-based and synthetic alternatives, pharmaceutical companies have more options for stabilizers and emulsifiers that may offer similar or improved functionalities without the potential drawbacks associated with egg proteins. These alternatives can provide solutions for those with allergies or dietary restrictions and may be perceived as more sustainable or cost-effective. As the market for alternative ingredients expands, the demand for egg proteins may be affected, challenging the market growth.
- Allergies to Egg Proteins
Allergies to egg proteins present a significant challenge in the widespread use of these proteins in pharmaceuticals. For individuals with egg allergies, exposure to egg proteins can trigger adverse reactions, which limits their suitability in drug formulations. This constraint necessitates careful consideration and labeling of pharmaceutical products to ensure the safety of consumers. The presence of egg proteins in medications must be managed to avoid allergic reactions, thereby impacting their broader adoption in the market. As a result, the prevalence of egg allergies can restrict the use of egg proteins, affecting their market potential and prompting the exploration of alternative ingredients.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Recent Developments
- 2024 年 6 月，美国生物科技公司 EVERY Co. 宣布与加拿大 Landish Foods（北美营养保健产品领导者）建立合作伙伴关系。双方将共同推出 FERMY，这是一款用于饮料的全新即食蛋白粉系列，其特色是经过精密发酵提取的蛋清蛋白
- 2023 年 12 月，配料创新者 EVERY 推出了其旗舰产品 EVERY Egg，这是世界上第一款不含母鸡的液体鸡蛋。EVERY Egg 是通过酵母发酵制成的，经过 EVERY 九年的产品开发后推出的
鸡蛋蛋白在医药市场的应用范围
市场根据类型、口味、形式、功能、应用和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 蛋清粉
- 蛋黄粉
- 全蛋蛋白质
口味
- 口味
- 常规的
形式
- 坚硬的
- 液体
- 粉末
功能
- 绑定
- 结晶
- 乳化
- 发酵
- 防腐剂
- 增稠
应用
- 面包和糖果
- 膳食补充剂
- 喂养
- 食品和饮料
- 冰淇淋
- 肉制品
- 个人护理和化妆品
- 蛋白质和营养棒
分销渠道
- 便利店
- 医疗和药店
- 在线商店
- 超市/大卖场
鸡蛋蛋白在医药市场的区域分析
对市场进行分析，并按上述国家、类型、口味、形式、功能、应用和分销渠道提供市场规模洞察和趋势。
市场覆盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷以及南美洲其他地区。
由于蛋白质补充剂消费量不断增长以及鸡蛋蛋白质产量增加，北美预计将占据市场主导地位。对富含蛋白质的产品的需求量很大，再加上生产技术和基础设施的进步，支撑了北美的市场领导地位。
由于各类市场参与者的不断增加以及这些国家工业能力的快速发展，亚太地区预计将出现显著增长。人们对健康和营养的认识不断提高，加上可支配收入的增加，推动了对基于鸡蛋蛋白的药物的需求。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在对国家数据进行预测分析时，还考虑了区域品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。
鸡蛋蛋白在医药市场的份额分析
市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、区域存在、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
在市场上运营的一些主要市场参与者包括：
- Eat Just, Inc.（美国）
- IntegriCulture Inc.（日本）
- Aleph Farms（以色列）
- AVANTMEATS（中国）
- Believer Meats（美国）
- newprotein（阿根廷）
- BioFood Systems Ltd.（以色列）
- Meatable（荷兰）
- Mission Barns（美国）
- BlueNalu (美国)
- Simple Foods Inc.（美国）
- Shiok Meats（新加坡）
- CUBIQ FOODS SL（西班牙）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
